SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-22-116466
Filing Date
2022-11-09
Accepted
2022-11-09 16:07:07
Documents
64
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cldx-20220930x10q.htm   iXBRL 10-Q 1401348
2 EXHIBIT-3.1 cldx-20220930xex3d1.htm EX-3.1 158571
3 EXHIBIT-10.1 cldx-20220930xex10d1.htm EX-10.1 288071
4 EXHIBIT-10.2 cldx-20220930xex10d2.htm EX-10.2 42033
5 EXHIBIT 31.1 cldx-20220930xex31d1.htm EX-31.1 15024
6 EXHIBIT 31.2 cldx-20220930xex31d2.htm EX-31.2 15004
7 EXHIBIT 32.1 cldx-20220930xex32d1.htm EX-32.1 9465
  Complete submission text file 0001104659-22-116466.txt   6765086

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA cldx-20220930.xsd EX-101.SCH 31485
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cldx-20220930_cal.xml EX-101.CAL 45651
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cldx-20220930_def.xml EX-101.DEF 142033
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cldx-20220930_lab.xml EX-101.LAB 335825
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cldx-20220930_pre.xml EX-101.PRE 245543
58 EXTRACTED XBRL INSTANCE DOCUMENT cldx-20220930x10q_htm.xml XML 1354455
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 221372563
SIC: 2835 In Vitro & In Vivo Diagnostic Substances